Jury Says Kite Pharma Owes $752M For Infringing Patent
A California federal jury awarded Juno Therapeutics and Sloan Kettering $752 million on Friday after finding that Kite Pharma willfully infringed a patent for cancer immunotherapy, bringing a dramatic end to...To view the full article, register now.
Already a subscriber? Click here to view full article